No Data
No Data
No Data
No Data
No Data
Amphastar Pharmaceuticals Poised for Growth: Strong Generic Pipeline and Strategic Marketing Drive Buy Rating
TipRanksApr 17 11:35 ET
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shareholders YoY Returns Are Lagging the Company's 66% Three-year Earnings Growth
Yahoo FinanceApr 12 10:26 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amphastar Pharmaceuticals (AMPH), Ascendis Pharma (ASND) and AMN Healthcare Services (AMN)
TipRanksApr 12 09:41 ET
Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies
At the Needham Healthcare Conference, Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) highlighted why they remain excited about Baqsimi, the inhaled glucagon product for severe hypoglycemia. Amphastar Pha
BenzingaApr 10 15:23 ET
Express News | Needham Reiterates Hold on Amphastar Pharma
Moomoo 24/7Apr 10 07:24 ET
Needham Sticks to Its Hold Rating for Amphastar Pharmaceuticals (AMPH)
TipRanksApr 10 06:56 ET
No Data
No Data